Nonalcoholic Fatty Liver Disease clinical trials at UCSF
9 in progress, 5 open to eligible people
Bicalutamide Therapy in Young Women With NAFLD and PCOS
open to eligible females ages 18-42
Nonalcoholic steatohepatitis (NASH), or fat-related liver inflammation and scarring is projected to be the leading cause of cirrhosis in the United States (U.S.) within the next few years. Women are at disproportionate risk for NASH, with…
San Francisco, California
Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis
open to eligible people ages 30-70
Participants meeting study entry criteria are randomized with equal probability to one of two study groups: (1) Lifestyle modification or (2) Vertical Sleeve Gastrectomy (VSG) with Iifestyle modification, followed for 12 months. The primary goal for …
San Francisco, California and other locations
Androgens and NAFLD Longitudinal Cohort Study
open to eligible females ages 18-42
The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when fat builds up in the liver which can cause damage to the liver such as inflammation or…
San Francisco, California and other locations
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
open to eligible people ages 18 years and up
The recent development of dissolution dynamic nuclear polarization (DNP) technology for hyperpolarized (HP) 13C imaging offers a promising new avenue for non-invasively accessing fundamental metabolic changes associated with the progression of fatty …
San Francisco, California
Nonalcoholic Fatty Liver Disease in HIV Database
open to eligible people ages 18 years and up
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions associated with fat accumulation that ranges from benign, non-progressive liver fat accumulation to severe liver injury, cirrhosis, and liver failure. The spectrum of NAFLD…
San Francisco, California and other locations
Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Sorry, in progress, not accepting new patients
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will either get semaglutide or a dummy medicine - which…
San Francisco, California and other locations
Vitamin E Dosing Study
Sorry, in progress, not accepting new patients
This is a multicenter, randomized, double masked, placebo-controlled, parallel treatment groups dosing trial of Vitamin E in adult nonalcoholic fatty liver disease (NAFLD).
San Francisco, California and other locations
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Sorry, in progress, not accepting new patients
The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of…
San Francisco, California and other locations
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
Sorry, not currently recruiting here
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions associated with fat accumulation that ranges from benign, non-progressive liver fat accumulation to severe liver injury, cirrhosis, and liver failure. NAFLD is the most…
San Francisco, California and other locations
Our lead scientists for Nonalcoholic Fatty Liver Disease research studies include Michael Ohliger, MD Bilal Hameed, MD Monika Sarkar Jennifer Price, MD.
Last updated: